Jeremy Segal

1.7k total citations
27 papers, 1.1k citations indexed

About

Jeremy Segal is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jeremy Segal has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Jeremy Segal's work include Acute Myeloid Leukemia Research (11 papers), Cancer Genomics and Diagnostics (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Jeremy Segal is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Cancer Genomics and Diagnostics (6 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Jeremy Segal collaborates with scholars based in United States, India and Brazil. Jeremy Segal's co-authors include Simon Monard, Agnès Viale, Jeffrey M. Friedman, Sarah Rowland‐Jones, Martin Markowitz, Graham S. Ogg, Arlene Hurley, David D. Ho, Xia Jin and Yaming Cao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Jeremy Segal

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy Segal United States 14 426 337 192 187 187 27 1.1k
Jennifer E. Wu United States 17 280 0.7× 1.1k 3.2× 145 0.8× 258 1.4× 26 0.1× 19 1.7k
Sadahiko Iwamoto Japan 22 35 0.1× 139 0.4× 93 0.5× 355 1.9× 488 2.6× 81 1.6k
Angelica Petraroli Italy 23 57 0.1× 635 1.9× 42 0.2× 341 1.8× 91 0.5× 61 1.5k
John G. Gartner Canada 19 38 0.1× 572 1.7× 56 0.3× 262 1.4× 293 1.6× 52 1.5k
Lillie Lopez United States 15 478 1.1× 376 1.1× 124 0.6× 358 1.9× 17 0.1× 16 1.4k
Qin Ouyang Germany 17 57 0.1× 834 2.5× 39 0.2× 139 0.7× 50 0.3× 33 1.4k
J F Delfraissy France 15 170 0.4× 521 1.5× 69 0.4× 110 0.6× 103 0.6× 25 912
Sandra Columba‐Cabezas Italy 21 115 0.3× 1.1k 3.2× 138 0.7× 552 3.0× 21 0.1× 30 2.1k
Mónica Marta United Kingdom 20 39 0.1× 761 2.3× 205 1.1× 307 1.6× 99 0.5× 66 1.9k
Claudia Rossi Italy 15 36 0.1× 137 0.4× 160 0.8× 880 4.7× 88 0.5× 19 1.4k

Countries citing papers authored by Jeremy Segal

Since Specialization
Citations

This map shows the geographic impact of Jeremy Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Segal more than expected).

Fields of papers citing papers by Jeremy Segal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Segal. The network helps show where Jeremy Segal may publish in the future.

Co-authorship network of co-authors of Jeremy Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Segal. A scholar is included among the top collaborators of Jeremy Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Segal. Jeremy Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Segal, Jeremy, Sandeep Gurbuxani, Irene Helenowski, et al.. (2022). Therapy‐related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype. British Journal of Haematology. 197(6). 736–744. 8 indexed citations
3.
Sukhanova, Madina, Kai Lee Yap, Jeremy Segal, et al.. (2022). MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia. Leukemia & lymphoma. 63(6). 1436–1444. 5 indexed citations
4.
Petras, Kristin, Kelly Arndt, Pankhuri Wanjari, et al.. (2022). Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders. Human Mutation. 43(7). 950–962. 17 indexed citations
5.
Karube, Kennosuke, Caner Saygin, Sandeep Gurbuxani, et al.. (2022). B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas. Human Pathology. 125. 48–58. 3 indexed citations
6.
Parilla, Megan, et al.. (2020). A Tale of 2 Morphologies: Diagnostic Pitfalls in TFEB-Associated Renal Cell Carcinomas, Including a Novel NEAT1-TFEB Fusion. International Journal of Surgical Pathology. 29(1). 21–29. 5 indexed citations
7.
Tjota, Melissa Y., Heather Chen, Megan Parilla, et al.. (2020). Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous. The American Journal of Surgical Pathology. 44(7). 943–954. 62 indexed citations
8.
Cahill, Kirk E., Yasmin Karimi, Theodore Karrison, et al.. (2020). A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia. Blood Advances. 4(4). 599–606. 8 indexed citations
9.
Ritterhouse, Lauren L., Megan Parilla, Chao Jie Zhen, et al.. (2019). Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing. Molecular Diagnosis & Therapy. 23(6). 791–802. 13 indexed citations
10.
11.
Patel, Sanjay S., Geraldine S. Pinkus, Lauren L. Ritterhouse, et al.. (2019). High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia. American Journal of Hematology. 94(8). 921–928. 19 indexed citations
12.
Drazer, Michael W., Sabah Kadri, Madina Sukhanova, et al.. (2018). Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Advances. 2(2). 146–150. 65 indexed citations
13.
Segal, Jeremy, et al.. (2017). PS02.23 CCDC6-RET Fusion as a Mechanism of Acquired EGFR Resistance. Journal of Thoracic Oncology. 12(11). S1573–S1573. 2 indexed citations
14.
Neistadt, Barbara, Rafael Márquez, Amittha Wickrema, et al.. (2016). Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy. Biology of Blood and Marrow Transplantation. 22(11). 2100–2103. 32 indexed citations
15.
Márquez, Rafael, Amittha Wickrema, Andrew Artz, et al.. (2015). Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy. Blood. 126(23). 3163–3163. 1 indexed citations
16.
Stanley, Sarah A., Shirly Pinto, Jeremy Segal, et al.. (2010). Identification of neuronal subpopulations that project from hypothalamus to both liver and adipose tissue polysynaptically. Proceedings of the National Academy of Sciences. 107(15). 7024–7029. 154 indexed citations
17.
Preminger, Beth Aviva, et al.. (2009). An Operative Approach to the Treatment of Refractory Cutaneous Nasal Sarcoid. Annals of Plastic Surgery. 63(6). 685–887. 4 indexed citations
18.
Laghi, Franco, et al.. (2005). Hypogonadism in Men with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 171(7). 728–733. 55 indexed citations
19.
Ogg, Graham S., Xia Jin, Sebastian Bonhoeffer, et al.. (1999). Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy. Journal of Virology. 73(1). 797–800. 292 indexed citations
20.
Olson, William C., Gwénaël Rabut, Kirsten Nagashima, et al.. (1999). Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5. Journal of Virology. 73(5). 4145–4155. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer E. Wu Breakdown of academic impact, for papers by Sadahiko Iwamoto Breakdown of academic impact, for papers by Angelica Petraroli Breakdown of academic impact, for papers by John G. Gartner Breakdown of academic impact, for papers by Lillie Lopez Breakdown of academic impact, for papers by Qin Ouyang Breakdown of academic impact, for papers by J F Delfraissy Breakdown of academic impact, for papers by Sandra Columba‐Cabezas Breakdown of academic impact, for papers by Mónica Marta Breakdown of academic impact, for papers by Claudia Rossi
Rankless by CCL
2026